Nutritional ketosis and mitohormesis: potential implications for mitochondrial function and human health

VJ Miller, FA Villamena, JS Volek - Journal of nutrition and …, 2018 - Wiley Online Library
Impaired mitochondrial function often results in excessive production of reactive oxygen
species (ROS) and is involved in the etiology of many chronic diseases, including …

AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure

C Beauloye, L Bertrand, S Horman… - Cardiovascular …, 2011 - academic.oup.com
Heart failure is a progressive muscular disorder leading to a deterioration of the heart
characterized by a contractile dysfunction and a chronic energy deficit. As a consequence …

Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications

C Penna, MG Perrelli, P Pagliaro - Antioxidants & redox signaling, 2013 - liebertpub.com
Reperfusion therapy is the indispensable treatment of acute myocardial infarction (AMI) and
must be applied as soon as possible to attenuate the ischemic insult. However, reperfusion …

AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation

EP Daskalopoulos, C Dufeys, L Bertrand… - Journal of Molecular and …, 2016 - Elsevier
Fibrosis is a general term encompassing a plethora of pathologies that span all systems and
is marked by increased deposition of collagen. Injury of variable etiology gives rise to …

GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats

T Inoue, T Inoguchi, N Sonoda, H Hendarto… - Atherosclerosis, 2015 - Elsevier
Objective Accumulating evidence has implicated that GLP-1 may have a beneficial effect on
cardiovascular but the mechanism is not fully understood. Here we show that GLP-1 analog …

The neurometabolic axis: A novel therapeutic target in heart failure

P Chakraborty, SS Po, BJ Scherlag, TW Dasari - Life Sciences, 2023 - Elsevier
Abnormal cardiac metabolism or cardiac metabolic remodeling is reported before the onset
of heart failure with reduced ejection fraction (HFrEF) and is known to trigger and maintain …

Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo

T Pulinilkunnil, H He, D Kong, K Asakura… - Journal of Biological …, 2011 - ASBMB
AMP-activated protein kinase (AMPK), an evolutionarily conserved serine-threonine kinase
that senses cellular energy status, is activated by stress and neurohumoral stimuli. We …

Leptin activates hepatic 5′-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of …

L Miyamoto, K Ebihara, T Kusakabe, D Aotani… - Journal of Biological …, 2012 - ASBMB
Leptin is an adipocyte-derived hormone that regulates energy homeostasis. Leptin treatment
strikingly ameliorates metabolic disorders of lipodystrophy, which exhibits ectopic fat …

Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease

DS Hutchinson, RJ Summers, T Bengtsson - Pharmacology & therapeutics, 2008 - Elsevier
G-protein coupled receptors (GPCRs) comprise the largest and most diverse family of
membrane receptors in the human genome, relaying information from a vast array of …

Targeting adrenergic receptors in metabolic therapies for heart failure

DM Perez - International Journal of Molecular Sciences, 2021 - mdpi.com
The heart has a reduced capacity to generate sufficient energy when failing, resulting in an
energy-starved condition with diminished functions. Studies have identified numerous …